Results 151 to 160 of about 218,193 (340)
Abnormal clinical presentation and surgical outcome of an intraventricular cavernoma of the third ventricle. [PDF]
Maupin CM +3 more
europepmc +1 more source
Innovation and the role of the cardiac morphologist [PDF]
Aiello, VD +4 more
core +1 more source
TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2
This study identifies the E3 ligase TRIM40 as a key driver of pathological cardiac hypertrophy. TRIM40 binds PKN2 via its B‐box domain and, through its C29‐dependent catalytic activity, mediates K63‐linked ubiquitination of PKN2. This modification enhances PKN2 phosphorylation at Ser815, thereby driving hypertrophy.
Risheng Zhao +12 more
wiley +1 more source
Soft, Flexible, and Stretchable Platforms for Tissue‐Interfaced Bioelectronics
Bio‐integrated electronics provide mechanically compliant and stable interfaces with soft biological tissues. Representative applications include neural interfaces, wet‐organadhesive electronics, and skin‐interfaced devices. E represents Young´s modulus and ε represents strain.
Kento Yamagishi +3 more
wiley +1 more source
A bioinspired piezoelectric sensor mimicking Pacinian corpuscles is developed to enable ultrasensitive and linear pressure sensing. A multilayer grooved architecture converts normal pressure into in‐plane strain, delivering high sensitivity, wide linear range, and efficient energy harvesting, enabling high‐fidelity wrist pulse monitoring and ...
Qi Yang +8 more
wiley +1 more source
Endoscopic ultrasonic resection of calcified tumor of the third ventricle. [PDF]
Spennato P +6 more
europepmc +1 more source
A 3D endoscopic transtubular transcallosal approach to the third ventricle [PDF]
Alireza Shoakazemi +4 more
openalex +1 more source
Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases
Mitochondrial transplantation (MTx) offers a promising therapeutic avenue for mitochondrial diseases. This review comprehensively evaluates MTx, differentiating its feasibility for mtDNA‐ and nDNA‐based disorders. It examines its potential for genetic correction, alongside inherent limitations, technical challenges, and crucial ethical considerations ...
Parmeshar Singh +17 more
wiley +1 more source

